The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced ...
Straight Arrow News (English) on MSN
FDA to review Moderna's mRNA flu vaccine after initial rejection
Moderna announced that the FDA will review its new mRNA flu vaccine, a reversal less than two weeks after the agency refused ...
The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the ...
With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.
US drug regulator originally refused to consider application, fueling critics’ concern about alleged ‘anti-vaccine agenda’ ...
Moderna announced that the FDA agreed to review its application for a mRNA-based flu vaccine after it agreed to further study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results